volume 26, issue 2, P255-262 2011
DOI: 10.3233/jad-2011-110329
View full text
|
Sign up to set email alerts
|
Share

Abstract: The quantitative analysis of peptides in human cerebrospinal fluid (CSF) has become an important step in the early diagnosis of dementia, e.g., Alzheimer's disease. In search of new biomarkers for early detection and differential diagnosis of chronic neurodegenerative diseases, "biobanking" and long-term storage of human samples is increasingly important. The German Dementia Competence Network (DCN) has accomplished one of the largest biomaterial banks in this field, comprising CSF from several hundreds of pat…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

1
17
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals